Table 5.
IFNγ IL-4 |
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Control patient |
---|---|---|---|---|---|---|---|---|---|---|
Pre | - - |
4 - |
- - |
- - |
- - |
- - |
8 - |
105 - |
6 - |
- - |
1 month | 4 - |
5 - |
- - |
7 - |
- - |
4 - |
4 - |
293 3.54 |
- - |
|
3 months | 24 - |
5 - |
- - |
4 - |
- - |
7 - |
4 - |
4 - |
||
6 months | 4 - |
8 - |
- - |
4 - |
4 - |
270 2.05 |
- - |
|||
9 months | - - |
|||||||||
12 months | 4 - |
- - |
- - |
- - |
66 - |
5 - |
- - |